LOS ANGELES (Jun. 16, 2020) — Chintan Parekh, MD, of The Saban Research Institute of Children’s Hospital Los Angeles, has led a team of investigators that generated a comprehensive roadmap for how T
CHLA scientists work toward a new therapy to target resistant leukemia. Their study, recently published in the journal Leukemia, shows that these new CAR-T cells could be the answer to resistant
Patients with acute lymphoblastic leukemia are at increased risk for bone fractures due to bone loss resulting from treatment. This decrease in bone density (as illustrated here) can occur as soon as
Sex-based differences in incidence and long-term outcomes have been well documented in pediatric cancer patients. Investigators at Children’s Hospital Los Angeles have now discovered similar
Actually, it can hide. CHLA’s Yong-Mi Kim tells us exactly how leukemia burrows within bone marrow, where it is shielded from cancer treatments. But given Kim’s breakthrough research on acute